Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032
Overview
The Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is expected to reach a 2.17 USD Billion by 2032 and is projected to grow at a CAGR of 6.25% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.34
Forecast, 2032 (USD Billion)
2.17
CAGR, 2024 - 2032
6.25%
Report Coverage
Middle East & Africa
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market 2018-2032 USD Billion
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.34 USD Billion
- Projected Market Size (2032): 2.17 USD Billion
- CAGR (2025-2032): 6.25%
Key Findings of Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market
- The Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market was valued at 1.34 USD Billion in 2024.
- The Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is likely to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Modern in Mode Segment accounted for the largest share of the market with a revenue of 1.00 USD Billion
- The fastest growing segment Immunology in Application Segment grew Fastest with a CAGR of 6.76% during the forecast period from 2024 to 2032.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Scope
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope
Product
- Monoclonal Antibodies (Derived from Plasma Cells)
- Other Plasma Derived Proteins
- Protease Inhibitors (For Genetic Deficiencies)
- Albumin (Plasma Volume Expander)
- Coagulation Factors (For Bleeding Disorders)
- Immunoglobulins
Application
- Rheumatology
- Haemato-Oncology
- Pulmonology
- Other Applications
- Neurology
- Critical Care
- Hematology
- Immunology
Distribution Channel
- Others
- Third Party Distributors
- Direct Tenders
End User
- Academic Institutes
- Others
- Research Labs
- Hospitals & Clinics
Mode
- Traditional Plasma Fractionation
- Modern
Processing Technology
- Microfiltration
- Ultrafiltration
- Cryoprecipitation
- Affinity Chromatography
- Ion Exchange Chromatography
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.34 USD Billion |
| Market Value in 2032 | 2.17 USD Billion |
| CAGR (2025-2032) | 6.25% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Application,Distribution Channel,End User,Mode,Processing Technology |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 1.34 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 392.43 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Product
- Immunoglobulins is the largest segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 568.25 USD Billion in the year 2024.
- Coagulation Factors (For Bleeding Disorders) is the Fastest growing segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.30 % in forecast period 2025-2032.
-
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Application
- Immunology is the largest segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 446.01 USD Billion in the year 2024.
- Immunology is the Fastest growing segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.76 % in forecast period 2025-2032.
-
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 705.72 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.63 % in forecast period 2025-2032.
-
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By End User
- Hospitals & Clinics is the largest segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 919.98 USD Billion in the year 2024.
- Hospitals & Clinics is the Fastest growing segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.54 % in forecast period 2025-2032.
-
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Mode
- Modern is the largest segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 1.00 USD Billion in the year 2024.
- Modern is the Fastest growing segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.37 % in forecast period 2025-2032.
-
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Processing Technology
- Ion Exchange Chromatography is the largest segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 414.72 USD Billion in the year 2024.
- Affinity Chromatography is the Fastest growing segment in Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.34 % in forecast period 2025-2032.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Company Share Analysis
| Company Name |
|
||
| Octapharma AG | |||
| Kedrion S.p.A | |||
| Takeda Pharmaceutical Company Limited | |||
| Grifols, S.A. | |||
| CSL | |||
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Application,Distribution Channel,End User,Mode,Processing Technology.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 1.34(Revenue in USD Billion) in 2024.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
The Modern segment is expected to dominate the Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market, holding a largest market share of 1.00 USD Billion in 2024
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Scope
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope
Product
- Monoclonal Antibodies (Derived from Plasma Cells)
- Other Plasma Derived Proteins
- Protease Inhibitors (For Genetic Deficiencies)
- Albumin (Plasma Volume Expander)
- Coagulation Factors (For Bleeding Disorders)
- Immunoglobulins
Application
- Rheumatology
- Haemato-Oncology
- Pulmonology
- Other Applications
- Neurology
- Critical Care
- Hematology
- Immunology
Distribution Channel
- Others
- Third Party Distributors
- Direct Tenders
End User
- Academic Institutes
- Others
- Research Labs
- Hospitals & Clinics
Mode
- Traditional Plasma Fractionation
- Modern
Processing Technology
- Microfiltration
- Ultrafiltration
- Cryoprecipitation
- Affinity Chromatography
- Ion Exchange Chromatography
Frequently Asked Questions
The Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Application,Distribution Channel,End User,Mode,Processing Technology.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 1.34(Revenue in USD Billion) in 2024.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market for final year is USD 2.17 (USD Billion).
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Application,Distribution Channel,End User,Mode,Processing Technology.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 1.34(Revenue in USD Billion) in 2024.
Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 6.25% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Blood Plasma & Plasma Derived Medicinal Products Market for final year is USD 2.17 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 7500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.